SPOTLIGHT: Accelerator launches fourth biotech venture

Seattle-based Accelerator has launched a new blood diagnostic company. The biotech says it can develop new diagnostic techniques for the early diagnosis of disease. This is the fourth biotech venture to come out of the incubator. Article

Suggested Articles

Biotech leaders criticized the dismissals of Chinese scientists from U.S. universities in a letter with more than 150 signatures.

In this week's EuroBiotech Report, Merck allies with Themis on vaccine R&D, Juvenescence raises $100 million and GSK files for anemia approval. 

In our EuroBiotech roundup this week, Scancell withdraws IND, Oxurion’s eye drug fails phase 2a and Abivax starts ulcerative colitis trial.